There is great news for parents suffering the harrowing ordeal of their child needing a bone marrow transplant. The announcement came from Osiris Therapeutics Inc. (NASDAQ: OSIR) on Friday that Health Canada has approved its groundbreaking stem cell therapy Prochymal? (remestemcel-L). The drug can be used to treat children with acute graft-vs-host disease. (GvHD). The decision is a historic one, as it's both the first stem cell drug going into formal use, as well as the first treatment for GvHD...
Realtime Related Tweets
transcendentalism bells palsy channel 5 news uc berkeley harrison barnes brett ratner stevie nicks
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.